Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 10
2021 13
2022 11
2023 21
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Sequencing Systemic Therapy in Hepatocellular Carcinoma.
Ponvilawan B, Roth MT. Ponvilawan B, et al. Curr Treat Options Oncol. 2023 Nov;24(11):1580-1597. doi: 10.1007/s11864-023-01135-7. Epub 2023 Oct 16. Curr Treat Options Oncol. 2023. PMID: 37843628 Review.
Molecular patterns identify distinct subclasses of myeloid neoplasia.
Kewan T, Durmaz A, Bahaj W, Gurnari C, Terkawi L, Awada H, Ogbue OD, Ahmed R, Pagliuca S, Awada H, Kubota Y, Mori M, Ponvilawan B, Al-Share B, Patel BJ, Carraway HE, Scott J, Balasubramanian SK, Bat T, Madanat Y, Sekeres MA, Haferlach T, Visconte V, Maciejewski JP. Kewan T, et al. Among authors: ponvilawan b. Nat Commun. 2023 May 30;14(1):3136. doi: 10.1038/s41467-023-38515-4. Nat Commun. 2023. PMID: 37253784 Free PMC article.
Advancements and future trends of immunotherapy in light-chain amyloidosis.
Mahadevia H, Ponvilawan B, Sharma P, Al-Obaidi A, Qasim H, Koyi J, Anwer F, Raza S. Mahadevia H, et al. Among authors: ponvilawan b. Crit Rev Oncol Hematol. 2023 Mar;183:103917. doi: 10.1016/j.critrevonc.2023.103917. Epub 2023 Jan 22. Crit Rev Oncol Hematol. 2023. PMID: 36696931 Review.
Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia.
Bahaj W, Kewan T, Gurnari C, Durmaz A, Ponvilawan B, Pandit I, Kubota Y, Ogbue OD, Zawit M, Madanat Y, Bat T, Balasubramanian SK, Awada H, Ahmed R, Mori M, Meggendorfer M, Haferlach T, Visconte V, Maciejewski JP. Bahaj W, et al. Among authors: ponvilawan b. J Hematol Oncol. 2023 Aug 3;16(1):91. doi: 10.1186/s13045-023-01480-y. J Hematol Oncol. 2023. PMID: 37537667 Free PMC article.
Atypical Femoral Fracture in Hypophosphatasia: A Systematic Review.
Charoenngam N, Thongpiya J, Yingchoncharoen P, Ponvilawan B, Marangoz MS, Chenbhanich J, Ungprasert P. Charoenngam N, et al. Among authors: ponvilawan b. Int J Endocrinol. 2023 Sep 12;2023:5544148. doi: 10.1155/2023/5544148. eCollection 2023. Int J Endocrinol. 2023. PMID: 37731773 Free PMC article.
Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets.
Mori M, Kubota Y, Durmaz A, Gurnari C, Goodings C, Adema V, Ponvilawan B, Bahaj WS, Kewan T, LaFramboise T, Meggendorfer M, Haferlach C, Barnard J, Wlodarski M, Visconte V, Haferlach T, Maciejewski JP. Mori M, et al. Among authors: ponvilawan b. Leukemia. 2023 Oct;37(10):2082-2093. doi: 10.1038/s41375-023-02003-x. Epub 2023 Aug 26. Leukemia. 2023. PMID: 37634012 Free PMC article.
59 results